Replying to:
Nicolas André, Kelvin Tsai, Manon Carré, Eddy Pasquier from the Service d’Hématologie et Oncologie Pédiatrique, Hôpital pour Enfants de La Timone, the Inserm CRO2 UMR_S 911, Aix-Marseille University, the CNRS, INSERM, Aix-Marseille University, Institut Paoli-Calmettes, CCRCM, Marseille, France and the Laboratories for Tumor Aggressiveness and Stemness; National Institute of Cancer Research, National Health Research Institutes; College of Medicine, Taipei Medical University, Taiwan and the (...)